{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:05Z","timestamp":1786997885625,"version":"build-2736575974"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.vaccine.2011.11.021","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T16:29:04Z","timestamp":1321547344000},"page":"614-625","source":"Crossref","is-referenced-by-count":31,"title":["Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax\u00ae using proteome microarrays and development of recombinant protein ELISAs"],"prefix":"10.1016","volume":"30","author":[{"given":"Gary","family":"Hermanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sookhee","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozelyn","family":"Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Nakajima-Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Huw","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"February (RR-4)","key":"10.1016\/j.vaccine.2011.11.021_bib0005","first-page":"1","article-title":"Smallpox vaccination and adverse reactions. Guidance for clinicians","volume":"52","author":"Cono","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"December (52)","key":"10.1016\/j.vaccine.2011.11.021_bib0010","doi-asserted-by":"crossref","first-page":"8807","DOI":"10.1016\/j.vaccine.2007.10.040","article-title":"Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3","volume":"25","author":"Osborne","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.11.021_bib0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des Devel Ther"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.11.021_bib0020","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.09.55","article-title":"The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks","volume":"8","author":"Handley","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2011.11.021_bib0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"eigenschaften und verwendung des attenuierten vaccinia-stammes MVA","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"issue":"December (5\u20136)","key":"10.1016\/j.vaccine.2011.11.021_bib0030","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol [B]"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2011.11.021_bib0040","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"issue":"May (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.11.021_bib0050","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1099\/vir.0.83156-0","article-title":"Genomic sequence of chorioallantois vaccinia virus Ankara, the ancestor of modified vaccinia virus Ankara","volume":"88","author":"Meisinger-Henschel","year":"2007","journal-title":"J Gen Virol"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2011.11.021_bib0055","doi-asserted-by":"crossref","first-page":"9907","DOI":"10.1128\/JVI.00756-10","article-title":"Introduction of the six major genomic deletions of modified vaccinia virus Ankara (MVA) into the parental vaccinia virus is not sufficient to reproduce an MVA-like phenotype in cell culture and in mice","volume":"84","author":"Meisinger-Henschel","year":"2010","journal-title":"J Virol"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.11.021_bib0060","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2006.02.012","article-title":"Protection induced in mice against a lethal orthopox virus by the Lister strain of vaccinia virus and modified vaccinia virus Ankara (MVA)","volume":"24","author":"Abdalrhman","year":"2006","journal-title":"Vaccine"},{"issue":"March (6979)","key":"10.1016\/j.vaccine.2011.11.021_bib0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2011.11.021_bib0070","first-page":"283","article-title":"[An attenuated strain of vaccinia virus (MVA). Successful intramuscular immunization against vaccinia and variola (author's transl)]","volume":"230","author":"Hochstein-Mintzel","year":"1975","journal-title":"Zentralbl Bakteriol [Orig A]"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model","volume":"339","author":"Meseda","year":"2005","journal-title":"Virology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.vaccine.2006.07.022","article-title":"Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine","volume":"25","author":"Phelps","year":"2007","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.11.021_bib0085","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"June (27)","key":"10.1016\/j.vaccine.2011.11.021_bib0095","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2011.11.021_bib0100","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2011.11.021_bib0105","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"October (21)","key":"10.1016\/j.vaccine.2011.11.021_bib0110","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1073\/pnas.93.21.11341","article-title":"Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety","volume":"93","author":"Moss","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.021_bib0115","doi-asserted-by":"crossref","first-page":"867","DOI":"10.4161\/hv.9693","article-title":"Attenuated poxvirus vectors MVA and NYVAC as promising vaccine candidates against HIV\/AIDS","volume":"5","author":"Esteban","year":"2009","journal-title":"Hum Vaccine"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/156652308784049363","article-title":"The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer","volume":"8","author":"Gomez","year":"2008","journal-title":"Curr Gene Ther"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2011.11.021_bib0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/erv.09.4","article-title":"Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara","volume":"8","author":"Rimmelzwaan","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.4161\/hv.6.1.10116","article-title":"Prime-boost vectored malaria vaccines: progress and prospects","volume":"6","author":"Hill","year":"2010","journal-title":"Hum Vaccine"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.11.021_bib0135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1086\/590185","article-title":"Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa","volume":"198","author":"Hawkridge","year":"2008","journal-title":"J Infect Dis"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2011.11.021_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2174\/156652305774329230","article-title":"Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines","volume":"5","author":"Xing","year":"2005","journal-title":"Curr Gene Ther"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.021_bib0145","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1517\/14712590802567298","article-title":"Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer","volume":"8","author":"Tykodi","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0150","first-page":"185","article-title":"Discovery and development of therapeutic cancer vaccines","volume":"10","author":"Acres","year":"2007","journal-title":"Curr Opin Drug Discov Devel"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0155","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol Rev"},{"issue":"June","key":"10.1016\/j.vaccine.2011.11.021_bib0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","article-title":"Immunity and immunological memory following smallpox vaccination","volume":"211","author":"Amanna","year":"2006","journal-title":"Immunol Rev"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.11.021_bib0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2011.11.021_bib0170","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0175","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J Virol"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.11.021_bib0180","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/IAI.00048-08","article-title":"A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi","volume":"76","author":"Barbour","year":"2008","journal-title":"Infect Immun"},{"issue":"April (15)","key":"10.1016\/j.vaccine.2011.11.021_bib0185","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1073\/pnas.1001323107","article-title":"A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray","volume":"107","author":"Crompton","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2011.11.021_bib0190","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/pmic.200800194","article-title":"Profiling humoral immune responses to P. falciparum infection with protein microarrays","volume":"8","author":"Doolan","year":"2008","journal-title":"Proteomics"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.11.021_bib0195","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1002\/pmic.200600985","article-title":"Immunodominant Francisella tularensis antigens identified using proteome microarray","volume":"7","author":"Eyles","year":"2007","journal-title":"Proteomics"},{"issue":"August (32)","key":"10.1016\/j.vaccine.2011.11.021_bib0200","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1073\/pnas.0812080106","article-title":"A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens","volume":"106","author":"Felgner","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2010.05.011","article-title":"High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays","volume":"405","author":"Luevano","year":"2010","journal-title":"Virology"},{"issue":"December","key":"10.1016\/j.vaccine.2011.11.021_bib0210","article-title":"Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays","author":"Molina","year":"2009","journal-title":"Vaccine"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.11.021_bib0215","doi-asserted-by":"crossref","first-page":"i508","DOI":"10.1093\/bioinformatics\/btm207","article-title":"From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis","volume":"23","author":"Sundaresh","year":"2007","journal-title":"Bioinformatics"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2011.11.021_bib0220","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/pmic.201000064","article-title":"Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray","volume":"10","author":"Vigil","year":"2010","journal-title":"Proteomics"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2011.11.021_bib0225","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.80.5.2127-2140.2006","article-title":"Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.virol.2006.08.025","article-title":"Protein composition of the vaccinia virus mature virion","volume":"358","author":"Resch","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.11.021_bib0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-3-10","article-title":"Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins","volume":"3","author":"Yoder","year":"2006","journal-title":"Virol J"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0240","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/JVI.01706-07","article-title":"Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax","volume":"82","author":"Davies","year":"2008","journal-title":"J Virol"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2011.11.021_bib0245","doi-asserted-by":"crossref","first-page":"7120","DOI":"10.1128\/JVI.00453-08","article-title":"An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling","volume":"82","author":"Jing","year":"2008","journal-title":"J Virol"},{"issue":"August (1\u20132)","key":"10.1016\/j.vaccine.2011.11.021_bib0250","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jim.2009.05.011","article-title":"ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans","volume":"347","author":"Jing","year":"2009","journal-title":"J Immunol Methods"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0255","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr Purif"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.11.021_bib0260","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1093\/bioinformatics\/18.suppl_1.S105","article-title":"A variance-stabilizing transformation for gene-expression microarray data","volume":"18","author":"Durbin","year":"2002","journal-title":"Bioinformatics"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2011.11.021_bib0265","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","article-title":"Variance stabilization applied to microarray data calibration and to the quantification of differential expression","volume":"18","author":"Huber","year":"2002","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2011.11.021_bib0270","series-title":"DNA Microarrays and Gene Expression From Experiments to Data Analysis and Modeling","author":"Baldi","year":"2002"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2011.11.021_bib0275","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/bioinformatics\/btl162","article-title":"Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques","volume":"22","author":"Sundaresh","year":"2006","journal-title":"Bioinformatics"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.11.021_bib0280","doi-asserted-by":"crossref","first-page":"i508","DOI":"10.1093\/bioinformatics\/btm207","article-title":"From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis","volume":"23","author":"Sundaresh","year":"2007","journal-title":"Bioinformatics"},{"issue":"September (13)","key":"10.1016\/j.vaccine.2011.11.021_bib0285","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/bioinformatics\/bth193","article-title":"DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results","volume":"20","author":"Kreil","year":"2004","journal-title":"Bioinformatics"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.11.021_bib0290","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/bioinformatics\/17.6.509","article-title":"A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes","volume":"17","author":"Baldi","year":"2001","journal-title":"Bioinformatics"},{"issue":"June (23)","key":"10.1016\/j.vaccine.2011.11.021_bib0295","doi-asserted-by":"crossref","first-page":"19937","DOI":"10.1074\/jbc.M010192200","article-title":"Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K12","volume":"276","author":"Long","year":"2001","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2011.11.021_bib0300","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc Ser B"},{"issue":"June (24)","key":"10.1016\/j.vaccine.2011.11.021_bib0305","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1001\/jama.289.24.3295","article-title":"Response to smallpox vaccine in persons immunized in the distant past","volume":"289","author":"Frey","year":"2003","journal-title":"JAMA"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2011.11.021_bib0310","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"issue":"December (51)","key":"10.1016\/j.vaccine.2011.11.021_bib0315","doi-asserted-by":"crossref","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2008.07.025","article-title":"Electrocardiography screening for cardiotoxicity after modified Vaccinia Ankara vaccination","volume":"122","author":"Sano","year":"2009","journal-title":"Am J Med"},{"issue":"August (Pt 8)","key":"10.1016\/j.vaccine.2011.11.021_bib0325","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1099\/vir.0.010553-0","article-title":"Evaluation of smallpox vaccines using variola neutralization","volume":"90","author":"Damon","year":"2009","journal-title":"J Gen Virol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0330","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0042-6822(92)90046-R","article-title":"Frame-shift mutations within the vaccinia virus A-type inclusion protein gene","volume":"186","author":"Amegadzie","year":"1992","journal-title":"Virology"},{"issue":"October (Suppl 2)","key":"10.1016\/j.vaccine.2011.11.021_bib0335","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1201-9712(04)00134-1","article-title":"ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) \u2013 a second-generation smallpox vaccine for biological defense","volume":"8","author":"Monath","year":"2004","journal-title":"Int J Infect Dis"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.11.021_bib0485","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1086\/651561","article-title":"Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration","volume":"201","author":"Wilck","year":"2010","journal-title":"J Infect Dis"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2011.11.021_bib0345","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/651560","article-title":"Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax","volume":"201","author":"Seaman","year":"2010","journal-title":"J Infect Dis"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.11.021_bib0350","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1128\/JVI.02244-07","article-title":"Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine","volume":"82","author":"Benhnia","year":"2008","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.11.021_bib0355","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0360","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.icb.7100118","article-title":"Correlates of protective immunity in poxvirus infection: where does antibody stand?","volume":"86","author":"Panchanathan","year":"2008","journal-title":"Immunol Cell Biol"},{"issue":"September (37)","key":"10.1016\/j.vaccine.2011.11.021_bib0365","doi-asserted-by":"crossref","first-page":"16262","DOI":"10.1073\/pnas.1005769107","article-title":"Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo","volume":"107","author":"Rimoin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0370","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/viro.1999.0096","article-title":"DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge","volume":"266","author":"Hooper","year":"2000","journal-title":"Virology"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2011.11.021_bib0375","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2011.11.021_bib0380","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J Virol"},{"issue":"December (Pt 12)","key":"10.1016\/j.vaccine.2011.11.021_bib0385","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2011.11.021_bib0390","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0065-3527(06)66002-8","article-title":"In a nutshell: structure and assembly of the vaccinia virion","volume":"66","author":"Condit","year":"2006","journal-title":"Adv Virus Res"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2011.11.021_bib0395","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1128\/JVI.74.16.7508-7517.2000","article-title":"Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail","volume":"74","author":"da Fonseca","year":"2000","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.11.021_bib0400","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.021_bib0405","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.1128\/JVI.73.10.8750-8761.1999","article-title":"Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells","volume":"73","author":"Hsiao","year":"1999","journal-title":"J Virol"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.11.021_bib0410","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0021-9258(19)40055-0","article-title":"Structural and functional characterization of a cell surface binding protein of vaccinia virus","volume":"265","author":"Maa","year":"1990","journal-title":"J Biol Chem"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.021_bib0415","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/JVI.62.10.3772-3778.1988","article-title":"Vaccinia virus gene D8 encodes a virion transmembrane protein","volume":"62","author":"Niles","year":"1988","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.11.021_bib0420","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"Berhanu","year":"2008","journal-title":"J Virol"},{"issue":"Nov (2)","key":"10.1016\/j.vaccine.2011.11.021_bib0425","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2006.07.017","article-title":"Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen","volume":"355","author":"Sakhatskyy","year":"2006","journal-title":"Virology"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.11.021_bib0430","doi-asserted-by":"crossref","first-page":"7404","DOI":"10.1128\/JVI.71.10.7404-7420.1997","article-title":"Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment","volume":"71","author":"Salmons","year":"1997","journal-title":"J Virol"},{"issue":"August (16)","key":"10.1016\/j.vaccine.2011.11.021_bib0435","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1128\/JVI.78.16.8885-8901.2004","article-title":"Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions","volume":"78","author":"Unger","year":"2004","journal-title":"J Virol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.11.021_bib0440","doi-asserted-by":"crossref","first-page":"9285","DOI":"10.1128\/JVI.71.12.9285-9294.1997","article-title":"The vaccinia virus I1 protein is essential for the assembly of mature virions","volume":"71","author":"Klemperer","year":"1997","journal-title":"J Virol"},{"issue":"September (6)","key":"10.1016\/j.vaccine.2011.11.021_bib0445","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1083\/jcb.200504026","article-title":"External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice","volume":"170","author":"Szajner","year":"2005","journal-title":"J Cell Biol"},{"issue":"January (Pt 1)","key":"10.1016\/j.vaccine.2011.11.021_bib0450","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1099\/0022-1317-69-1-35","article-title":"Cloning and characterization of the gene encoding the major protein of the A-type inclusion body of cowpox virus","volume":"69","author":"Funahashi","year":"1988","journal-title":"J Gen Virol"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2011.11.021_bib0455","first-page":"7592","article-title":"Congregation of orthopoxvirus virions in cytoplasmic A-type inclusions is mediated by interactions of a bridging protein (A26p) with a matrix protein (ATIp) and a virion membrane-associated protein (A27p)","volume":"84","author":"Howard","year":"2011","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.11.021_bib0460","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody response against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat Med"},{"issue":"Aug (8)","key":"10.1016\/j.vaccine.2011.11.021_bib0465","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1128\/CVI.00050-07","article-title":"Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines","volume":"14","author":"Garcia","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2011.11.021_bib0470","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.11.021_bib0475","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.11.021_bib0480","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/502450","article-title":"Smallpox vaccine: non-take responses in previously vaccinated adults","volume":"25","author":"Thomas","year":"2004","journal-title":"Infect Control Hosp Epidemiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11017889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T01:48:00Z","timestamp":1741916880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11017889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0264410X11017889"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}